EUVIMEDEUVIMED entdecken
Crossref

Collective Intelligence Versus Corporate Monopoly: The future of AI in healthcare

Yanyi Wu, Chenghua Lin

Ubiquity · 01.03.2026 · 2026 (March) · 1-12

DOI: 10.1145/3723882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ubiquity, online erschienen am 25.03.2026. Verfasst von Yanyi Wu und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As artificial intelligence (AI) revolutionizes healthcare, a crucial debate is emerging: Should AI development be driven by tech giants or by collective intelligence? This article discusses the strengths and limitations of both approaches, analyzing real-world cases and future scenarios. The investigation encompasses technical, ethical, and practical implications of different AI development models in healthcare, drawing insights from initiatives like Google's Med-PaLM 2 and the MIMIC database. A balanced path integrating corporate innovation with open-source collaboration, supported by thoughtful regulation, may offer a promising way to develop AI systems that are technologically advanced, ethical, and equitable. The integrated approach could help address diverse needs in global healthcare while maintaining high standards of innovation and accessibility.

Zitieren

APA

Wu, Y., & Lin, C. (2026). Collective Intelligence Versus Corporate Monopoly: The future of AI in healthcare. Ubiquity, 2026(March), 1-12. https://doi.org/10.1145/3723882

Vancouver

Wu Y, Lin C. Collective Intelligence Versus Corporate Monopoly: The future of AI in healthcare. Ubiquity. 2026;2026(March):1-12. doi:10.1145/3723882

BibTeX
@article{Wu2026,
  author = {Wu, Yanyi and Lin, Chenghua},
  title = {Collective Intelligence Versus Corporate Monopoly: The future of AI in healthcare},
  journal = {Ubiquity},
  year = {2026},
  volume = {2026},
  number = {March},
  pages = {1--12},
  doi = {10.1145/3723882}
}
Kostenlos starten →